Literature DB >> 31419292

HIV-Associated Vacuolar Encephalomyelopathy.

Gregory R Madden1, Molly E Fleece1, Akriti Gupta2, M Beatriz S Lopes2, Scott K Heysell1, Christopher J Arnold1, Brian Wispelwey1.   

Abstract

We report a case of human immunodeficiency virus (HIV)-associated vacuolar encephalomyelopathy with progressive central nervous system dysfunction and corresponding vacuolar degeneration of the spinal cord, cranial nerves, and brain, the anatomic extent of which has not previously been described. Published by Oxford University Press on behalf of Infectious Diseases Society of America 2019.

Entities:  

Keywords:  AIDS; HIV; Vacuolar Myelopathy

Year:  2019        PMID： 31419292      PMCID： PMC6767965          DOI： 10.1093/ofid/ofz366

Source DB:  PubMed          Journal:  Open Forum Infect Dis        ISSN： 2328-8957            Impact factor:   3.835


  11 in total

1.  Pilot study of intravenous immunoglobulin in HIV-associated myelopathy.

Authors:  Katia Cikurel; Lauren Schiff; David M Simpson
Journal:  AIDS Patient Care STDS       Date:  2009-02       Impact factor: 5.078

2.  Vacuolar myelopathy associated with optic neuropathy in an HIV-negative, immunosuppressed liver transplant recipient.

Authors:  S R L Stacpoole; R Phadke; T S Jacques; T Revesz; G T Plant
Journal:  J Neurol Neurosurg Psychiatry       Date:  2009-05       Impact factor: 10.154

3.  Spinal MRI in vacuolar myelopathy, and correlation with histopathological findings.

Authors:  S Sartoretti-Schefer; T Blättler; W Wichmann
Journal:  Neuroradiology       Date:  1997-12       Impact factor: 2.804

4.  Diagnostic challenges in vacuolar myelopathy: a didactic case report.

Authors:  Florian Ernst; Fritz Klausner; Waltraud Kleindienst; Heinrich Bartsch; Ninon Taylor; Eugen Trinka
Journal:  Spinal Cord Ser Cases       Date:  2016-09-15

5.  MR findings in AIDS-associated myelopathy.

Authors:  J Chong; A Di Rocco; M Tagliati; F Danisi; D M Simpson; S W Atlas
Journal:  AJNR Am J Neuroradiol       Date:  1999-09       Impact factor: 3.825

6.  Clinicopathologic correlations of HIV-1-associated vacuolar myelopathy: an autopsy-based case-control study.

Authors:  G J Dal Pan; J D Glass; J C McArthur
Journal:  Neurology       Date:  1994-11       Impact factor: 9.910

7.  Vacuolar myelopathy pathologically resembling subacute combined degeneration in patients with the acquired immunodeficiency syndrome.

Authors:  C K Petito; B A Navia; E S Cho; B D Jordan; D C George; R W Price
Journal:  N Engl J Med       Date:  1985-04-04       Impact factor: 91.245

8.  Vacuolar myelopathy in AIDS. A morphological analysis.

Authors:  J Artigas; G Grosse; F Niedobitek
Journal:  Pathol Res Pract       Date:  1990-04       Impact factor: 3.250

9.  Treatment of AIDS-associated myelopathy with L-methionine: a placebo-controlled study.

Authors:  A Di Rocco; P Werner; T Bottiglieri; J Godbold; M Liu; M Tagliati; A Scarano; D Simpson
Journal:  Neurology       Date:  2004-10-12       Impact factor: 9.910

Review 10.  Hypothesis on the pathogenesis of vacuolar myelopathy, dementia, and peripheral neuropathy in AIDS.

Authors:  S V Tan; R J Guiloff
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-07       Impact factor: 10.154
View more
  2 in total

1.  Human immunodeficiency virus-associated vacuolar encephalomyelopathy with granulomatous-lymphocytic interstitial lung disease improved after antiretroviral therapy: a case report.

Authors:  Kazumasa Akagi; Kazuko Yamamoto; Asuka Umemura; Shotaro Ide; Tatsuro Hirayama; Takahiro Takazono; Yoshifumi Imamura; Taiga Miyazaki; Noriho Sakamoto; Hirokazu Shiraishi; Hideaki Takahata; Yoshiaki Zaizen; Junya Fukuoka; Minoru Morikawa; Kazuto Ashizawa; Katsuji Teruya; Koichi Izumikawa; Hiroshi Mukae
Journal:  AIDS Res Ther       Date:  2020-07-09       Impact factor: 2.250

2.  Atypical HIV-vacuolar myelopathy: a case report.

Authors:  Tau Mongezi; Joseph Sibi; George Jerry; Ibañez-Valdés Lourdes de Fátima; Dubula Tozama; Foyaca Sibat Humberto
Journal:  Eur J Med Res       Date:  2021-02-01       Impact factor: 2.175
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.